George Samantha, Martin Joshua Alexander James, Graziani Vittoria, Sanz-Moreno Victoria
Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, United Kingdom.
Front Cell Dev Biol. 2023 Jan 5;10:1091801. doi: 10.3389/fcell.2022.1091801. eCollection 2022.
Cell migration is crucial for efficient immune responses and is aberrantly used by cancer cells during metastatic dissemination. Amoeboid migrating cells use myosin II-powered blebs to propel themselves, and change morphology and direction. Immune cells use amoeboid strategies to respond rapidly to infection or tissue damage, which require quick passage through several barriers, including blood, lymph and interstitial tissues, with complex and varied environments. Amoeboid migration is also used by metastatic cancer cells to aid their migration, dissemination and survival, whereby key mechanisms are hijacked from professionally motile immune cells. We explore important parallels observed between amoeboid immune and cancer cells. We also consider key distinctions that separate the lifespan, state and fate of these cell types as they migrate and/or fulfil their function. Finally, we reflect on unexplored areas of research that would enhance our understanding of how tumour cells use immune cell strategies during metastasis, and how to target these processes.
细胞迁移对于有效的免疫反应至关重要,而癌细胞在转移扩散过程中会异常利用这一过程。阿米巴样迁移细胞利用肌球蛋白II驱动的泡来推动自身,并改变形态和方向。免疫细胞采用阿米巴样策略对感染或组织损伤迅速做出反应,这需要快速穿过包括血液、淋巴和间质组织在内的多个屏障,这些组织环境复杂多样。转移性癌细胞也利用阿米巴样迁移来辅助其迁移、扩散和存活,在此过程中,关键机制是从具有专业运动能力的免疫细胞中劫持而来的。我们探讨了在阿米巴样免疫细胞和癌细胞之间观察到的重要相似之处。我们还考虑了在这些细胞类型迁移和/或发挥其功能时,区分它们的寿命、状态和命运的关键差异。最后,我们思考了尚未探索的研究领域,这些领域将增进我们对肿瘤细胞在转移过程中如何利用免疫细胞策略以及如何靶向这些过程的理解。